Brokerages Set Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Price Target at $3.33
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) has earned a consensus recommendation of “Hold” from the five ...